Human CLEC10A/CD301 Alexa Fluor® 488-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # FAB48881G
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Gln61-His316
Accession # Q8IUN9
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human CLEC10A/CD301 Alexa Fluor® 488-conjugated Antibody
Detection of CLEC10A/CD301 in Human Dendritic Cells by Flow Cytometry.
Human immature dendritic cells were stained with Mouse Anti-Human CLEC10A/CD301 Alexa Fluor® 488-conjugated Monoclonal Antibody (Catalog # FAB48881G, filled histogram) or isotype control antibody (Catalog # IC0041G, open histogram). View our protocol for Staining Membrane-associated Proteins.Applications for Human CLEC10A/CD301 Alexa Fluor® 488-conjugated Antibody
Flow Cytometry
Sample: Human immature dendritic cells
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: CLEC10A/CD301
CLEC10A, also known as macrophage galactose/N-acetyl-galactosamine (GalNAc) specific lectin (MGL), CD301, DC-ASGPR, and HML, is a 40 kDa type II transmembrane glycoprotein that belongs to the C-type lectin family (1). Human and rat carry a single gene for CLEC10A/CD301, while mouse has two closely related MGL1 and MGL2 genes. Human CLEC10A/CD301 consists of a 39 amino acid (aa) cytoplasmic region, a 21 aa transmembrane segment and a 256 aa extracellular domain (ECD) with one carbohydrate recognition domain (CRD) and a neck region (2). Within the CRD, human CLEC10A/CD301 shares 64%-70% aa sequence identity with mouse MGL1, mouse MGL2, and rat MGL. Alternate splicing generates multiple isoforms of human CLEC10A/CD301 with 27 aa, 3 aa, and/or 4 aa deletions within the ECD (3, 4). CLEC10A/CD301 is expressed on immature myleloid dendritic cells and alternatively activated (tolerogenic) macrophages and is upregulated by the immunosuppressant dexamethasone (3-7). CLEC10A/CD301 selectively binds and internalizes terminal nonsialylated alpha- or beta-linked GalNAc moieties on O-linked carbohydrates, including the Tn carcinoma antigen (2-4, 8, 9). Similar ligand preference is exhibited by mouse MGL2 but not MGL1 (10). CLEC10A/CD301 expressed on tolerogenic dendritic cells binds carbohydrate determinants on CD45 (RA, RB, and RC but not RO isoforms) expressed by T, NK, and B cells (6). This interaction inhibits effector T cell activation and induces their apoptosis (6). CLEC10A/CD301 also binds the GP envelope glycoprotein on Marburg and Ebola viruses and enhances viral entry and infectivity (11).
References
- Zelensky, A.N. and J.E. Gready (2005) FEBS J. 272:6179.
- Suzuki, N. et al. (1996) J. Immunol. 156:128.
- Higashi, N. et al. (2002) J. Biol. Chem. 277:20686.
- Valladeau, J. et al. (2001) J. Immunol. 167:5767.
- van Vliet, S.J. et al. (2006) Immunobiology 211:577.
- van Vliet, S.J. et al. (2006) Nat. Immunol. 7:1200.
- Raes, G. et al. (2005) J. Leukoc. Biol. 77:321.
- van Vliet, S.J. et al. (2005) Int. Immunol. 17:661.
- Higashi, N. et al. (2002) Int. Immunol. 14:545.
- Tsuiji, M. et al. (2002) J. Biol. Chem. 277:28892.
- Takada, A. et al. (2004) J. Virol. 78:2943.
Long Name
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional CLEC10A/CD301 Products
Product Specific Notices for Human CLEC10A/CD301 Alexa Fluor® 488-conjugated Antibody
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
For research use only